Gut microbiome and obesity

Treatment of the Obese Patient

Volumn , Issue , 2014, Pages 73-82

  Flint, Harry J ^a   Duncan, Sylvia H ^a   Louis, Petra ^a  

^a ROWETT RESEARCH INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84929934985     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4939-1203-2_5     Document Type: Chapter

References (75)

1. Turnbaugh PJ, Ley RE, Mahowald MA, et al. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature. 2006;444:1027-31.
2. Backhed F, Ding H, Wang T, et al. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci USA. 2004;101:15718-23.
3. Blaut M, Klaus S. Intestinal microbiota and obesity. In: Joost H-G, editors. Appetite control. Handbook of experimental pharmacology vol 2.9 Heidelberg: Springer; 2012. DOI: 10.1007/978-3-642-24716-3-11.
4. Tagliabue A, Elli M. The role of gut microbiota in human obesity: recentfindings and future perspectives. Nutr Metab Cardiovasc Dis. 2013;23:160-8.
5. Flint HJ. Obesity and the gut microbiota. J Clin Gastroenterol. 2011;45:S128-132.
6. Tremaroli V, Kovatcheva-Datchary P, Backhed F. A role for the gut microbiota in energy harvesting? Gut. 2010;59:1589-90.
7. Everard A, Cani PD. Diabetes, obesity and gut microbiota. Best Pract Res Clin Gastroenterol. 2013;27:73-83.
8. Tap J, Mondot S, Levenez F, et al. Towards the human intestinal microbiota phylogenetic core. Environ Microbiol. 2009;11:2574-84.
9. Walker AW, Ince J, Duncan SH, et al. Dominant and diet-responsive groups of bacteria within the human colonic microbiota. ISME J. 2011;5:220-30.
10. Qin J, et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature. 2010;464:59-65.
11. Arumugam M, Raes J, Pelletier E, et al. Enterotypes of the human gut microbiome. Nature. 2011;473: 174-80.
12. Wu GD, Chen J, Hoffmann C, et al. Linking longterm dietary patterns with gut microbial enterotypes. Science. 2011;334:105-8.
13. Claesson MJ, Jeffery IB, Conde S, et al. Gut microbiota composition correlates with diet and health in the elderly. Nature. 2012;488:178-84.
14. Martínez I, Kim J, Duffy PR, Schlegel VL, Walter J. Resistant starches types 2 and 4 have differential effects on the composition of the fecal microbiota in human subjects. PLoS ONE. 2010;5:e15046.
15. Flint HJ, Scott KP, Louis P, Duncan SH. The role of the gut microbiota in nutrition and health. Nat Rev Gastroenterol Hepatol. 2012;9:577-89.
16. Macfarlane S, Macfarlane GT, Cummings JH. Review article: prebiotics in the gastrointestinal tract. Aliment Pharmacol Ther. 2006;24:710-4.
17. Bouhnik Y, Raskine L, Simoneau G, et al. The capacity of non-digestible carbohydrates to stimulate faecal bifi-dobacteria in healthy humans: A double blind, randomized, placebo-controlled, parallel-group, dose response relation study. Am J Clin Nutr. 2004;80:1658-64.
18. Ramirez-Farias C, Slezak K, Fuller Z, et al. Effect of inulin on the human gut microbiota: stimulation of Bifidobacterium adolescentis and Faecalibacterium prausnitzii. Br J Nutr. 2009;101:541-50.
19. De Filippo C, Cavalieri D, Di Paolo M, et al. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc Natl Acad Sci USA. 2010;107: 14691-6.
20. Duncan SH, Belenguer A, Holtrop G, et al. Reduced dietary intake of carbohydrates by obese subjects results in decreased concentrations of butyrate and butyrate-producing bacteria in feces. Appl Environ Microbiol. 2007;73:1073-8.
21. Russell WR, Gratz S, Duncan SH, et al. High protein, reduced carbohydrate diets promote metabolite profiles likely to be detrimental to colonic health. Am J Clin Nutr. 2011;93:1062-72.
22. Duncan SH, Lobley GE, Holtrop G, et al. Human colonic microbiota associated with diet, obesity and weight loss. Int J Obes. 2008;32:1720-4.
23. Ley RE, Turnbaugh PJ, Klein S, Gordon JI. Microbial ecology-human gut microbes associated with obesity. Nature. 2006;444:1022-3.
24. Schwiertz A, Tars D, Schafer K, et al. Microbiota and SCFA in lean and overweight healthy subjects. Obesity. 2009;18:190-5.
25. Turnbaugh PJ, Hamady M, Yatsunenko T, et al. A core microbiome in obese and lean twins. Nature. 2009; 457:480-4.
26. Jumpertz R, et al. Energy-balance studies reveal associations between gut microbes, caloric load, and nutrient absorption in humans. Am J Clin Nutr. 2011;94:58-65.
27. Zupanic ML, Cantarel BL, Liu Z, et al. Analysis of the gut microbiota in the old order Amish and its relation to the metabolic syndrome. PLoS ONE. 2012;7:e43052.
28. Le Chatelier E, Nielsen T, Qin J, et al. Richness of human gut microbiome correlates with metabolic markers. Nature. 2013;500:541-9.
29. Tims S, Derom C, Jonkers DM, et al. Microbiota conservation and BMI signatures in adult monozygotic twins. ISME J. 2013;7:707-17.
30. Yokota A, Fukiya S, Ooka T, Ogura Y, Hayashi T, Ishizuka S. Is bile acid a determinant of the gut microbiota on a high-fat diet? Gut Microbes. 2012;3:455-9.
31. Wu X, Ma C, Han L, et al. Molecular characterisation of the faecal microbiota in patients with type II diabetes. Curr Microbiol. 2010;61:69-78.
32. Larsen N, Vogensen FK, van den Berg FWJ, et al. Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS ONE. 2010;5:e9085.
33. Karlsson FH, Tremaroli V, Nookaew I, et al. Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature. 2013;498:99-105.
34. Qin J, Li Y, Cai Z, et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature. 2012;490:55-60.
35. Cotillard A, Kennedy SP, Kong LC, et al. Dietary intervention impact on gut microbiota richness. Nature. 2013;500:585-90.
36. Ridaura VK, Faith JJ, Rey FE, et al. Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science. 2013;341:1241214.
37. Stephen AM, Wiggins HS, Cummings JH. Effect of changing transit time on colonic microbial metabolism in man. Gut. 1987;28:601-9.
38. Chapman RW, Sillery JK, Graham MM, et al. Absorption of starch by healthy ileostomates: effect of transit time and of carbohydrate load. Am J Clin Nutr. 1985;41:1244-9.
39. Teixeira TFS, Grzeskowiak L, Franceschini SCC, et al. Higher level of faecal SCFA in women correlates with metabolic syndrome risk factors. Br J Nutr. 2013;109:914-9.
40. Patil DP, Dhotre DP, Chavan SG, et al. Molecular analysis of gut microbiota in obesity among Indian individuals. J Biosci. 2012;37:647-57.
41. Murphy EF, Cotter PD, Healy S, et al. Composition and energy harvesting capacity of the gut microbiota: relationship to diet, obesity and time in mouse models. Gut. 2010;59:1635-42.
42. Ze X, Duncan SH, Louis P, Flint HJ. Ruminococcus bromii is a keystone species for the degradation of resistant starch in the human colon. ISME J. 2012;6: 1535-43.
43. Walker AW, Duncan SH, Leitch ECM, et al. pH and peptide supply can radically alter bacterial populations and short-chain fatty acid ratios within microbial communities from the human colon. Appl Environ Microbiol. 2005;71:3692-700.
44. Zhang H, DiBaise JK, Zuccolo A, et al. Human gut microbiota in obesity and after gastric bypass. Proc Natl Acad Sci USA. 2008;106:2365-70.
45. Wood TA, Wallace RJ, Rowe A, et al. Encapsulated fumaric acid as a feed ingredient to decrease methane emissions. Anim Feed Sci Technol. 2009;152:62-71.
46. Miller TL, Wolin MJ. Pathways of acetate, propionate and butyrate formation by the human fecal microbialflora. Appl Environ Microbiol. 1996;62:1589-92.
47. Latham MJ, Wolin MJ. Fermentation of cellulose by Ruminococcusflavefaciens in the presence and absence of Methanobacterium ruminantium. Appl Environ Microbiol. 1977;34:297-301.
48. Robert C, Bernalier-Donadille A. The cellulolytic microflora of the human colon: evidence of microcrystalline cellulose-degrading bacteria in methaneexcreting subjects. FEMS Microbiol Ecol. 2003;46: 81-9.
49. Pimental M, Lin HC, Enayatt P, et al. Methane, a gas produced by enteric bacteria, slows intestinal transit and augments intestinal contractile activity. Am J Physiol Gastrointest Liver Physiol. 2006;290: G1089-95.
50. El Oufir L, Flourié B, Bruley des Varannes S, et al. Relations between transit time, fermentation products, and hydrogen consumingflora in healthy humans. Gut 1996; 38:870-7.
51. Cryan JF, Dinan TG. Mind-altering microorganisms: The impact of the gut microbiota on brain and behaviour. Nat Rev Neurosci. 2012;13:701-12.
52. Nicholson JK, Holmes E, Kinross J, et al. Host-gut microbiota metabolic interactions. Science. 2012;336: 1262-7.
53. Parks BW, Nam E, Org E, et al. Genetic control of obesity and gut microbiota composition in response to high-fat, high-sucrose diet in mice. Cell Metab. 2013;17:141-52.
54. Poutahidis T, Kleinewietfeld M, Smillie C, et al. Microbial reprogramming inhibits Western dietassociated obesity. PLoS ONE. 2013;8:e68596.
55. Everard A, Belzer C, Geurts L, et al. Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc Natl Acad Sci USA. 2013;110:9066-71.
56. Cani PD, Amar J, Iglesias MA, et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes. 2007;56:1761-72.
57. Cani PD, Delzenne NM. The gut microbiome as therapeutic target. Pharmacol Ther. 2011;130:202-12.
58. Erridge C, Attina T, Spickett CM, et al. A high-fat meal induces low-grade endotoxemia: evidence of a novel mechanism of postprandial inflammation. Am J Clin Nutr. 2007;86:1286-92.
59. Vijay-Kumar M, Aitken JD, Carvalho FA, et al. Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5. Science. 2010;328: 228-31.
60. Backhed F, Manchester JK, Semenkovich CF, Gordon JI. Mechanisms underlying the resistance to dietinduced obesity in germ-free mice. Proc Natl Acad Sci USA. 2007;104:979-84.
61. Fleissner CK, Huebel N, Mostafa M, et al. Absence of intestinal microbiota does not protect mice from dietinduced obesity. Br J Nutr. 2010;104:919-29.
62. Swartz TD, Sakar Y, Duca FA, Covasa M. Preserved adiposity in the Fischer 344 rat devoid of gut microbiota. FASEB J. 2013;27:1701-10.
63. Upadhyay V, Poroyko V, Kim T, et al. Lymphotoxin regulates commensal responses to enable diet-induced obesity. Nat Immunol. 2012;13:947-53.
64. Hudson BD, Murdoch H, Milligan G. Minireview: The effects of species ortholog and SNP variation on receptors for free fatty acids. Mol Endocrinol. 2013; 27:1177-87.
65. Kimura I, Inoue D, Maeda T, et al. Short-chain fatty acids and ketones directly regulate sympathetic nervous system via G protein-coupled receptor 41 (GPR41). Proc Natl Acad Sci USA. 2011;108:8030-5.
66. Kimura I, Ozawa K, Inoue D, et al. The gut microbiota suppresses insulin-mediated fat accumulation via the short-chair fatty acid receptor GPR43. Nat Commun. 2013;4:1829.
67. Tolhurst G, Heffron H, Lam YS, et al. Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2. Diabetes. 2012;61:364-71.
68. Arora T, Sharma R, Frost G. Propionate. Anti-obesity and satiety enhancing factor? Appetite. 2011;56: 511-5.
69. Gao Z, Yin J, Zhang J, et al. Butyrate improves insulin sensitivity and increases energy expenditure in mice. Diabetes. 2009;58:1509-17.
70. Dethlefsen L, Huse S, Sogin ML, et al. The pervasive effects of an antibiotic on the human gut microbiota as revealed by deep 16S rRNA sequencing. PLoS Biol. 2008;6:e280.
71. Trasande L, Blustein J, Liu M, et al. Infant antibiotic exposures and early-life body mass. Int J Obes (Lond). 2013;37:16-23.
72. Greenwood MR, Hirsch J. Postnatal development of adipocyte cellularity in the normal rat. J Lipid Res. 1974;15:474-83.
73. Cho I, Yamanishi S, Cox L, et al. Antibiotics in early life alter the murine colonic microbiome and adiposity. Nature. 2012;488:621-6.
74. Cani P, Bibiloni R, Knauf C, et al. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes. 2008;57:1470-81.
75. Flint HJ. Antibiotics and adiposity. Nature. 2012;488: 601-2.